T. Benedek, History of the development of corticosteroid therapy, Clin Exp Rheumatol. oct, vol.29, issue.5, pp.5-12, 2011.

J. Albaum, S. Youn, L. Levesque, A. Gershon, and S. Cadarette, Osteoporosis management among chronic glucocorticoid users: a systematic review, J Popul Ther Clin Pharmacol J Ther Popul Pharamcologie Clin, vol.21, issue.3, pp.486-504, 2014.

T. Petranova, I. Sheytanov, S. Monov, R. Nestorova, and R. Rashkov, Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment, Biotechnology & Biotechnological Equipment, vol.26, issue.6, pp.1127-1164, 2014.
DOI : 10.1002/art.23417

J. Lindholm, S. Juul, J. Jørgensen, J. Astrup, P. Bjerre et al., Incidence and Late Prognosis of Cushing's Syndrome: A Population-Based Study, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.1, pp.117-140, 2001.
DOI : 10.1210/jc.86.1.117

E. Valassi, A. Santos, M. Yaneva, M. Toth, C. Strasburger et al., The European Registry on Cushing's syndrome: 2-year experience. Baseline demographic and clinical characteristics, European Journal of Endocrinology, vol.165, issue.3, pp.383-92, 2011.
DOI : 10.1530/EJE-11-0272

A. Lacroix, R. Feelders, C. Stratakis, and L. Nieman, Cushing's syndrome, The Lancet, vol.386, issue.9996, pp.913-940, 2015.
DOI : 10.1016/S0140-6736(14)61375-1

L. Nieman, B. Biller, J. Findling, M. Murad, J. Newell-price et al., Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, vol.100, issue.8, pp.2807-2838, 2015.
DOI : 10.1210/jc.2015-1818

M. Debono and J. Newell-price, Subclinical hypercortisolism in adrenal incidentaloma, Current Opinion in Endocrinology & Diabetes and Obesity, vol.22, issue.3, pp.185-92, 2015.
DOI : 10.1097/MED.0000000000000151

R. Libé, I. Borget, C. Ronchi, B. Zaggia, M. Kroiss et al., Prognostic factors in stage III???IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study, Annals of Oncology, vol.26, issue.10, pp.2119-2144, 2015.
DOI : 10.1093/annonc/mdv329

R. Clayton, D. Raskauskiene, R. Reulen, and P. Jones, Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.3, pp.632-674, 2011.
DOI : 10.1210/jc.2010-1942

R. Feelders, S. Pulgar, A. Kempel, and A. Pereira, MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects, European Journal of Endocrinology, vol.167, issue.3, pp.311-337, 2012.
DOI : 10.1530/EJE-11-1095

R. Clayton, D. Raskauskiene, R. Reulen, and P. Jones, Mortality and Morbidity in Cushing's Disease over 50 Years in Stoke-on-Trent, UK: Audit and Meta-Analysis of Literature, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.3, pp.632-674, 2011.
DOI : 10.1210/jc.2010-1942

E. Canalis, G. Mazziotti, A. Giustina, and J. Bilezikian, Glucocorticoid-induced osteoporosis: pathophysiology and therapy, Osteoporosis International, vol.89, issue.10, pp.1319-1347, 2007.
DOI : 10.7326/0003-4819-125-12-199612150-00004

Z. Wu, N. Bucher, and S. Farmer, Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids., Molecular and Cellular Biology, vol.16, issue.8, pp.4128-4164, 1996.
DOI : 10.1128/MCB.16.8.4128

D. Glass, P. Bialek, J. Ahn, M. Starbuck, M. Patel et al., Canonical Wnt Signaling in Differentiated Osteoblasts Controls Osteoclast Differentiation, Developmental Cell, vol.8, issue.5, pp.751-64, 2005.
DOI : 10.1016/j.devcel.2005.02.017

T. Mancini, M. Doga, G. Mazziotti, and A. Giustina, Cushing's Syndrome and Bone, Pituitary, vol.30, issue.4, pp.249-52, 2004.
DOI : 10.1159/000061083

O. Brien, C. Jia, D. Plotkin, L. Bellido, T. Powers et al., Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength, Endocrinology. avr, vol.145, issue.4, pp.1835-1876, 2004.

E. Smith and B. Frenkel, Glucocorticoids Inhibit the Transcriptional Activity of LEF/TCF in Differentiating Osteoblasts in a Glycogen Synthase Kinase-3??-dependent and -independent Manner, Journal of Biological Chemistry, vol.272, issue.3, pp.2388-94, 2005.
DOI : 10.1086/368277

N. Lane, W. Yao, M. Balooch, R. Nalla, G. Balooch et al., Glucocorticoid-Treated Mice Have Localized Changes in Trabecular Bone Material Properties and Osteocyte Lacunar Size That Are Not Observed in Placebo-Treated or Estrogen-Deficient Mice, Journal of Bone and Mineral Research, vol.16, issue.3, pp.466-76, 2006.
DOI : 10.1007/BF00427310

R. Weinstein, Glucocorticoid-Induced Bone Disease, New England Journal of Medicine, vol.365, issue.1, pp.62-70, 2011.
DOI : 10.1056/NEJMcp1012926

R. Weinstein, Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity, Bone, vol.46, issue.3, pp.564-70, 2010.
DOI : 10.1016/j.bone.2009.06.030

S. Teitelbaum, Bone Resorption by Osteoclasts, Science, vol.289, issue.5484, pp.1504-1512, 2000.
DOI : 10.1126/science.289.5484.1504

D. Jia, C. O-'brien, S. Stewart, S. Manolagas, and R. Weinstein, Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone Density, Endocrinology, vol.147, issue.12, pp.5592-5601, 2006.
DOI : 10.1210/en.2006-0459

L. Tack, C. Tatsi, C. Stratakis, and M. Lodish, Effects of Glucocorticoids on Bone: What we can Learn from Pediatric Endogenous Cushing???s Syndrome, Hormone and Metabolic Research, vol.48, issue.11, pp.764-70, 2016.
DOI : 10.1055/s-0042-117721

R. Weinstein, R. Jilka, A. Parfitt, and S. Manolagas, Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone., Journal of Clinical Investigation, vol.102, issue.2, pp.274-82, 1998.
DOI : 10.1172/JCI2799

D. Carbonare, L. Arlot, M. Chavassieux, P. Roux, J. Portero et al., Comparison of Trabecular Bone Microarchitecture and Remodeling in Glucocorticoid-Induced and Postmenopausal Osteoporosis, Journal of Bone and Mineral Research, vol.6, issue.Suppl 1, pp.97-103, 2001.
DOI : 10.1093/geronj/45.5.M153

S. Cummings and L. Melton, Epidemiology and outcomes of osteoporotic fractures, The Lancet, vol.359, issue.9319, pp.1761-1768, 2002.
DOI : 10.1016/S0140-6736(02)08657-9

C. Cooper, E. Atkinson, S. Jacobsen, O. Fallon, W. Melton et al., Population-Based Study of Survival after Osteoporotic Fractures, American Journal of Epidemiology, vol.137, issue.9, pp.1001-1006, 1993.
DOI : 10.1093/oxfordjournals.aje.a116756

D. Carbonare, L. Giannini, and S. , Bone microarchitecture as an important determinant of bone strength, Journal of Endocrinological Investigation, vol.18, issue.Suppl.1, pp.99-105, 2004.
DOI : 10.1210/en.2002-220149

K. Briot, B. Cortet, C. Roux, L. Fardet, V. Abitbol et al., 2014 update of recommendations on the prevention and treatment of glucocorticoid-induced osteoporosis, Joint Bone Spine, vol.81, issue.6, pp.493-501, 2014.
DOI : 10.1016/j.jbspin.2014.10.001

J. Kanis, O. Johnell, A. Oden, H. Johansson, and E. Mccloskey, FRAX??? and the assessment of fracture probability in men and women from the UK, Osteoporosis International, vol.17, issue.Suppl 2, pp.385-97, 2008.
DOI : 10.1093/qjmed/hci029

E. Siris, S. Brenneman, P. Miller, E. Barrett-connor, Y. Chen et al., Predictive Value of Low BMD for 1-Year Fracture Outcomes Is Similar for Postmenopausal Women Ages 50-64 and 65 and Older: Results From the National Osteoporosis Risk Assessment (NORA), Journal of Bone and Mineral Research, vol.150, issue.S1, pp.1215-1235, 2004.
DOI : 10.1093/oxfordjournals.aje.a010040

E. Seeman and P. Delmas, Bone Quality ??? The Material and Structural Basis of Bone Strength and Fragility, New England Journal of Medicine, vol.354, issue.21, pp.2250-61, 2006.
DOI : 10.1056/NEJMra053077

K. Walker-bone, Recognizing and treating secondary osteoporosis, Nature Reviews Rheumatology, vol.44, issue.8, pp.480-92, 2012.
DOI : 10.1016/j.bone.2009.01.373

R. Eastell, D. Reid, J. Compston, C. Cooper, I. Fogelman et al., A UK Consensus Group on management of glucocorticoid-induced osteoporosis: an update, Journal of Internal Medicine, vol.11, issue.4, pp.271-92, 1998.
DOI : 10.1007/s002239900014

T. Van-staa, H. Leufkens, L. Abenhaim, B. Zhang, and C. Cooper, Oral corticosteroids and fracture risk: relationship to daily and cumulative doses, Rheumatology, vol.39, issue.12, pp.1383-1392, 2000.
DOI : 10.1093/rheumatology/39.12.1383

J. Kanis, H. Johansson, A. Oden, O. Johnell, C. De-laet et al., A Meta-Analysis of Prior Corticosteroid Use and Fracture Risk, Journal of Bone and Mineral Research, vol.359, issue.6, pp.893-902, 2004.
DOI : 10.1017/S0714980800009934

T. Van-staa, H. Leufkens, L. Abenhaim, B. Zhang, and C. Cooper, Use of oral corticosteroids and risk of fractures, J Bone Miner Res Off J Am Soc Bone Miner Res. août, vol.20, issue.1486, pp.1487-1494, 2000.

M. Cooper, E. Rabbitt, P. Goddard, W. Bartlett, M. Hewison et al., Osteoblastic 11??-Hydroxysteroid Dehydrogenase Type 1 Activity Increases With Age and Glucocorticoid Exposure, Journal of Bone and Mineral Research, vol.37, issue.6, pp.979-86, 2002.
DOI : 10.1007/978-3-642-81265-1_2

H. Russcher, P. Smit, E. Van-den-akker, E. Van-rossum, A. Brinkmann et al., Two Polymorphisms in the Glucocorticoid Receptor Gene Directly Affect Glucocorticoid-Regulated Gene Expression, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.10, pp.5804-5814, 2005.
DOI : 10.1210/jc.2005-0646

A. Szappanos, A. Patócs, J. Tõke, B. Boyle, M. Sereg et al., BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism, Clinical Endocrinology, vol.81, issue.5, pp.636-679, 2009.
DOI : 10.2174/0929867043363749

L. Trementino, G. Appolloni, L. Ceccoli, G. Marcelli, C. Concettoni et al., Bone complications in patients with Cushing???s syndrome: looking for clinical, biochemical, and genetic determinants, Osteoporosis International, vol.8, issue.5, pp.913-934, 2014.
DOI : 10.1038/nrendo.2011.233

A. Kawamata, M. Iihara, T. Okamoto, and T. Obara, Bone Mineral Density Before and After Surgical Cure of Cushing???s Syndrome Due to Adrenocortical Adenoma: Prospective Study, World Journal of Surgery, vol.138, issue.5, pp.890-896, 2008.
DOI : 10.1007/BF03347198

A. Van-der-eerden, M. Den-heijer, W. Oyen, and A. Hermus, Cushing's syndrome and bone mineral density: lowest Z scores in young patients, Neth J Med. avr, vol.65, issue.4, pp.137-178, 2007.

P. Vestergaard, J. Lindholm, J. Jørgensen, C. Hagen, H. Hoeck et al., Increased risk of osteoporotic fractures in patients with Cushing's syndrome, European Journal of Endocrinology, vol.146, issue.1, pp.51-57, 2002.
DOI : 10.1530/eje.0.1460051

L. Tauchmanovà, R. Pivonello, D. Somma, C. Rossi, R. et al., Bone Demineralization and Vertebral Fractures in Endogenous Cortisol Excess: Role of Disease Etiology and Gonadal Status, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.5, pp.1779-84, 2006.
DOI : 10.1210/jc.2005-0582

G. Luisetto, M. Zangari, V. Camozzi, M. Boscaro, N. Sonino et al., Recovery of Bone Mineral Density after Surgical Cure, but not by Ketoconazole Treatment, in Cushing's Syndrome, Osteoporosis International, vol.12, issue.11, pp.956-60, 2001.
DOI : 10.1007/s001980170025

N. Ohmori, K. Nomura, K. Ohmori, Y. Kato, T. Itoh et al., Osteoporosis Is More Prevalent in Adrenal than in Pituitary Cushing's Syndrome., Endocrine Journal, vol.50, issue.1, pp.1-7, 2003.
DOI : 10.1507/endocrj.50.1

M. Minetto, G. Reimondo, G. Osella, M. Ventura, A. Angeli et al., Bone loss is more severe in primary adrenal than in pituitary-dependent Cushing?s syndrome, Osteoporosis International, vol.20, issue.11, pp.855-61, 2004.
DOI : 10.1148/radiology.200.3.8756924

D. Chappard, E. Legrand, M. Basle, P. Fromont, J. Racineux et al., Altered trabecular architecture induced by Corticosteroids: A Bone Histomorphometric Study, Journal of Bone and Mineral Research, vol.10, issue.1, pp.676-85, 1996.
DOI : 10.1111/j.1365-2818.1993.tb03407.x

C. Francucci, P. Pantanetti, G. Garrapa, F. Massi, G. Arnaldi et al., Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma, Clinical Endocrinology, vol.102, issue.5, pp.587-93, 2002.
DOI : 10.1128/MCB.17.6.3181

T. Van-staa, R. Laan, I. Barton, S. Cohen, D. Reid et al., Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy, Arthritis & Rheumatism, vol.12, issue.11, pp.3224-3233, 2003.
DOI : 10.1093/qjmed/93.2.105

H. Lee, J. Je, J. Seo, Y. Na, and H. Yoo, Mutiple Spontaneous Rib Fractures in Patient with Cushing's Syndrome, Journal of Bone Metabolism, vol.21, issue.4, pp.277-82, 2014.
DOI : 10.11005/jbm.2014.21.4.277

G. Papadakis, B. Uebelhart, M. Goumaz, S. Zawadynski, and R. Rizzoli, An unusual case of hypercortisolism with multiple weight-bearing bone fractures. Clin Cases Miner Bone Metab Off J Ital Soc Osteoporos Miner Metab Skelet Dis, sept, vol.10, issue.3, pp.213-220, 2013.

R. Dufour, R. Winzenrieth, A. Heraud, D. Hans, and N. Mehsen, Generation and validation of a normative, age-specific reference curve for lumbar spine trabecular bone score (TBS) in French women, Osteoporosis International, vol.26, issue.2
DOI : 10.1007/s00774-007-0793-5

J. Aloia, M. Mikhail, G. Usera, R. Dhaliwal, and S. Islam, Trabecular bone score (TBS) in postmenopausal African American women, Osteoporosis International, vol.29, issue.3, pp.1155-61, 2015.
DOI : 10.1002/jbmr.2176

M. Iki, J. Tamaki, Y. Sato, R. Winzenrieth, S. Kagamimori et al., Age-related normative values of trabecular bone score (TBS) for Japanese women: the Japanese Population-based Osteoporosis (JPOS) study, Osteoporosis International, vol.12, issue.6, pp.245-52, 2015.
DOI : 10.1186/1471-2474-12-182

E. Mccloskey, A. Odén, N. Harvey, W. Leslie, D. Hans et al., A Meta-Analysis of Trabecular Bone Score in Fracture Risk Prediction and Its Relationship to FRAX, Journal of Bone and Mineral Research, vol.14, issue.3, pp.940-948, 2016.
DOI : 10.1016/j.jocd.2011.04.011

C. Muschitz, R. Kocijan, J. Haschka, D. Pahr, A. Kaider et al., TBS reflects trabecular microarchitecture in premenopausal women and men with idiopathic osteoporosis and low-traumatic fractures, Bone, vol.79, pp.259-66, 2015.
DOI : 10.1016/j.bone.2015.06.007

L. Pothuaud, P. Carceller, and D. Hans, Correlations between grey-level variations in 2D projection images (TBS) and 3D microarchitecture: Applications in the study of human trabecular bone microarchitecture, Bone, vol.42, issue.4, pp.775-87, 2008.
DOI : 10.1016/j.bone.2007.11.018

V. Bousson, C. Bergot, B. Sutter, T. Thomas, S. Bendavid et al., Trabecular Bone Score: Where are we now?, Joint Bone Spine, vol.82, issue.5, pp.320-325, 2015.
DOI : 10.1016/j.jbspin.2015.02.005

P. Martineau and W. Leslie, Trabecular bone score (TBS): Method and applications, Bone, vol.104, 2017.
DOI : 10.1016/j.bone.2017.01.035

M. Bandirali, A. Poloni, L. Sconfienza, C. Messina, G. Papini et al., Short-term precision assessment of trabecular bone score and bone mineral density using dual-energy X-ray absorptiometry with different scan modes: an in vivo study, European Radiology, vol.16, issue.7, pp.2194-2202, 2015.
DOI : 10.1016/j.jocd.2013.02.005

D. Krueger, J. Libber, and N. Binkley, Spine Trabecular Bone Score Precision, a Comparison Between GE??Lunar Standard and High-Resolution Densitometers, Journal of Clinical Densitometry, vol.18, issue.2, pp.226-258, 2015.
DOI : 10.1016/j.jocd.2014.11.003

S. Kolta, K. Briot, J. Fechtenbaum, S. Paternotte, G. Armbrecht et al., TBS result is not affected by lumbar spine osteoarthritis, Osteoporosis International, vol.86, issue.6, pp.1759-64, 2014.
DOI : 10.1007/s00223-009-9322-y

N. Harvey, C. Glüer, N. Binkley, E. Mccloskey, M. Brandi et al., Trabecular bone score (TBS) as a new complementary approach for osteoporosis evaluation in clinical practice, Bone, vol.78
DOI : 10.1016/j.bone.2015.05.016

D. Hans, A. Goertzen, M. Krieg, and W. Leslie, Bone microarchitecture assessed by TBS predicts osteoporotic fractures independent of bone density: The manitoba study, Journal of Bone and Mineral Research, vol.27, issue.2, pp.2762-2771, 2011.
DOI : 10.1002/sim.2929

R. Winzenrieth, F. Michelet, and D. Hans, Three-Dimensional (3D) Microarchitecture Correlations with 2D Projection Image Gray-Level Variations Assessed by Trabecular Bone Score Using High-Resolution Computed Tomographic Acquisitions: Effects of Resolution and Noise, Journal of Clinical Densitometry, vol.16, issue.3, pp.287-96, 2013.
DOI : 10.1016/j.jocd.2012.05.001

G. Mazzetti, C. Berger, W. Leslie, D. Hans, L. Langsetmo et al., Densitometer-Specific Differences in the Correlation Between Body Mass Index and Lumbar Spine Trabecular Bone Score, Journal of Clinical Densitometry, vol.20, issue.2, pp.233-241, 2017.
DOI : 10.1016/j.jocd.2016.11.003

S. Amnuaywattakorn, C. Sritara, C. Utamakul, W. Chamroonrat, A. Kositwattanarerk et al., Simulated increased soft tissue thickness artefactually decreases trabecular bone score: a phantom study, BMC Musculoskeletal Disorders, vol.18, issue.1, p.17, 2016.
DOI : 10.1016/j.jocd.2014.04.117

C. Frederic, A. Picard, B. Rabier, P. Muriel, and E. Vignon, Trabecular Bone Microarchitecture Alteration in Glucocorticoids Treated Women in Clinical Routine? : A TBS Evaluation, ASBMR 31st Annual Meeting, p.129

M. Paggiosi, N. Peel, and R. Eastell, The impact of glucocorticoid therapy on trabecular bone score in older women, Osteoporosis International, vol.22, issue.3, pp.1773-80, 2015.
DOI : 10.1359/jbmr.061206

E. Leib and R. Winzenrieth, Bone status in glucocorticoid-treated men and women, Osteoporosis International, vol.26, issue.11, pp.39-48, 2016.
DOI : 10.1002/jbmr.499

M. Chuang, T. Chuang, K. M. Wang, and Y. , Trabecular Bone Score Reflects Trabecular Microarchitecture Deterioration and Fragility Fracture in Female Adult Patients Receiving Glucocorticoid Therapy: A Pre-Post Controlled Study, BioMed Research International, vol.21, issue.3, p.4210217, 2017.
DOI : 10.1007/s00198-015-3211-1

Z. Belaya, D. Hans, L. Rozhinskaya, N. Dragunova, N. Sasonova et al., The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing???s syndrome, Archives of Osteoporosis, vol.3, issue.Suppl 3, p.44, 2015.
DOI : 10.1530/EJE-11-0272

A. Scillitani, G. Mazziotti, D. Somma, C. Moretti, S. Stigliano et al., Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how? Osteoporos Int J Establ Result Coop Eur Found Osteoporos Natl Osteoporos Found USA, févr, vol.25, issue.2, pp.441-447, 2014.

D. Somma, C. Pivonello, R. Loche, S. Faggiano, A. Klain et al., Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study, Clinical Endocrinology, vol.75, issue.3, pp.302-310, 2003.
DOI : 10.1210/er.19.2.203

A. Hermus, A. Smals, L. Swinkels, D. Huysmans, G. Pieters et al., Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome, J Clin Endocrinol Metab. oct, vol.80, issue.10, pp.2859-65, 1995.

C. Kristo, R. Jemtland, T. Ueland, K. Godang, and J. Bollerslev, Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: A prospective, long-term study, European Journal of Endocrinology, vol.154, issue.1, pp.109-127, 2006.
DOI : 10.1530/eje.1.02067

T. Costa, M. Paganotto, R. Radominski, C. Kulak, and V. Borba, Calcium metabolism, vitamin D and bone mineral density after bariatric surgery, Osteoporosis International, vol.17, issue.3, pp.757-64, 2015.
DOI : 10.1007/s11695-007-9063-9

V. Locascio, E. Bonucci, B. Imbimbo, P. Ballanti, S. Adami et al., Bone loss in response to long-term glucocorticoid therapy, Bone and Mineral, vol.8, issue.1, pp.39-51, 1990.
DOI : 10.1016/0169-6009(91)90139-Q

I. Chiodini, R. Viti, F. Coletti, G. Guglielmi, C. Battista et al., Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures, Clinical Endocrinology, vol.147, issue.2, pp.208-221, 2009.
DOI : 10.7326/0003-4819-147-8-200710160-00006

C. Fagour, S. Bardet, V. Rohmer, Y. Arimone, P. Lecomte et al., Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study, European Journal of Endocrinology, vol.160, issue.2, pp.257-64, 2009.
DOI : 10.1530/EJE-08-0299

S. Petersenn, J. Newell-price, J. Findling, F. Gu, M. Maldonado et al., High variability in baseline urinary free cortisol values in patients with Cushing's disease, Clinical Endocrinology, vol.88, issue.2, pp.261-270, 2014.
DOI : 10.1210/jc.2003-030234

S. Carcinome, 18-66) 49/31 Z score -1.97 (-5.15 à-0.06) -1.8 (-4 à -0.36) -1.8 (-2.9 à 0.9) -3.53 (-4,9 à -3), pp.15-25